Rational Design, Synthesis and Biological Evaluation of Novel Pyrazoline-Based Antiproliferative Agents in MCF-7 Cancer Cells
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rational Design, Synthesis and Biological Evaluation of Novel Pyrazoline-Based Antiproliferative Agents in MCF-7 Cancer Cells
Authors
Keywords
-
Journal
Pharmaceuticals
Volume 15, Issue 10, Pages 1245
Publisher
MDPI AG
Online
2022-10-11
DOI
10.3390/ph15101245
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A novel series of benzothiazepine derivatives as tubulin polymerization inhibitors with anti-tumor potency
- (2021) Bin Wang et al. BIOORGANIC CHEMISTRY
- Pyrazoline analogs as potential anticancer agents and their apoptosis, molecular docking, MD simulation, DNA binding and antioxidant studies
- (2021) Manish Rana et al. BIOORGANIC CHEMISTRY
- Effect of the dichloro-substitution on antiproliferative activity of phthalimide-thiazole derivatives. Rational design, synthesis, elastase, caspase 3/7, and EGFR tyrosine kinase activity and molecular modeling study
- (2021) Beata Donarska et al. BIOORGANIC CHEMISTRY
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Design, Synthesis, Anticancer Activity, and Solid Lipid Nanoparticle Formulation of Indole- and Benzimidazole-Based Compounds as Pro-Apoptotic Agents Targeting Bcl-2 Protein
- (2021) Manar I. Nagy et al. Pharmaceuticals
- From Celecoxib to a Novel Class of Phosphodiesterase 5 Inhibitors: Trisubstituted Pyrazolines as Novel Phosphodiesterase 5 Inhibitors with Extremely High Potency and Phosphodiesterase Isozyme Selectivity
- (2021) Mohammad Abdel-Halim et al. JOURNAL OF MEDICINAL CHEMISTRY
- Antiproliferative activity of thiazole and oxazole derivatives: A systematic review of in vitro and in vivo studies
- (2021) Nancy Y. Guerrero-Pepinosa et al. BIOMEDICINE & PHARMACOTHERAPY
- Design, synthesis, and biological evaluation of new pyrimidine-5-carbonitrile derivatives bearing 1,3-thiazole moiety as novel anti-inflammatory EGFR inhibitors with cardiac safety profile
- (2021) Salah A. Abdel-Aziz et al. BIOORGANIC CHEMISTRY
- Synthesis of new substituted pyridine derivatives as potent anti-liver cancer agents through apoptosis induction: In vitro, in vivo, and in silico integrated approaches
- (2021) Ahmed T.A. Boraei et al. BIOORGANIC CHEMISTRY
- AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings
- (2021) Jerome Eberhardt et al. Journal of Chemical Information and Modeling
- Quinoline‐based thiazolidinone derivatives as potent cytotoxic and apoptosis‐inducing agents through EGFR inhibition
- (2021) Mohamed S. Nafie et al. Chemical Biology & Drug Design
- Synthesis and biological evaluation of new derivatives of thieno-thiazole and dihydrothiazolo-thiazole scaffolds integrated with a pyrazoline nucleus as anticancer and multi-targeting kinase inhibitors
- (2021) Ismail M. M. Othman et al. RSC Advances
- Discovery of New Apoptosis-Inducing Agents for Breast Cancer Based on Ethyl 2-Amino-4,5,6,7-Tetra Hydrobenzo[b]Thiophene-3-Carboxylate: Synthesis, In Vitro, and In Vivo Activity Evaluation
- (2020) Emad M. Gad et al. MOLECULES
- Triaryl dicationic DNA minor-groove binders with antioxidant activity display cytotoxicity and induce apoptosis in breast cancer
- (2020) Mohamed S. Nafie et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Synthesis and biological evaluation of pyrazoline and pyrrolidine‐2,5‐dione hybrids as potential antitumor agents.
- (2020) Kalpana Tilekar et al. ChemMedChem
- Pyrazoline Hybrids as Promising Anticancer Agents: An Up-to-Date Overview
- (2020) Dimitris Matiadis et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Synthesis, characterization of some pyrazine derivatives as anti-cancer agents: In vitro and in Silico approaches
- (2020) Eman S. Tantawy et al. JOURNAL OF MOLECULAR STRUCTURE
- Antimicrobial and antiproliferative activities of novel synthesized 6‐(quinolin‐2‐ylthio) pyridine derivatives with molecular docking study as multi‐targeted JAK2/STAT3 inhibitors
- (2020) Mohamed S. Nafie et al. Chemical Biology & Drug Design
- Pharmacophore hybridization approach to discover novel pyrazoline-based hydantoin analogs with anti-tumor efficacy
- (2020) Neha Upadhyay et al. BIOORGANIC CHEMISTRY
- Design, Synthesis, Characterization and In Silico Molecular Docking Studies and In Vivo Anti-inflammatory Activity of Pyrazoline Clubbed Thiazolinone Derivatives
- (2020) Deepak Kumar Singh et al. LETTERS IN ORGANIC CHEMISTRY
- Transition From Heart Disease to Cancer as the Leading Cause of Death in the United States
- (2019) Stephen Sidney et al. ANNALS OF INTERNAL MEDICINE
- Synthesis and biological evaluation of novel xanthine derivatives as potential apoptotic antitumor agents
- (2019) Mohamed Hisham et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Thiazole-containing compounds as therapeutic targets for cancer therapy
- (2019) Prabodh Chander Sharma et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Heterocyclic compounds: 2-Pyrazolines are biological active as well as fluorescence agents, an Overview
- (2018) Pramod Singh Negi et al. Anti-Cancer Agents in Medicinal Chemistry
- Anticancer Potential of Thiazole Derivatives: A Retrospective Review
- (2018) Shweta Jain et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- A comprehensive review of protein kinase inhibitors for cancer therapy
- (2018) Radhamani Kannaiyan et al. Expert Review of Anticancer Therapy
- New azole derivatives showing antimicrobial effects and their mechanism of antifungal activity by molecular modeling studies
- (2017) İnci Selin Doğan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis, anticancer evaluation and pharmacokinetic study of novel 10- O -phenyl ethers of dihydroartemisinin
- (2017) Shenglin Luan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Unveiling a versatile heterocycle: pyrazoline – a review
- (2017) Beena Varghese et al. RSC Advances
- A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy
- (2016) John Y. Li et al. CANCER CELL
- Synthesis and cytotoxic activities of some pyrazoline derivatives bearing phenyl pyridazine core as new apoptosis inducers
- (2016) Riham F. George et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes
- (2016) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Molecular architecture of the ErbB2 extracellular domain homodimer
- (2015) Shi Hu et al. Oncotarget
- Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids
- (2014) Kunal Nepali et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Novel inhibitors of breast cancer relevant kinases Brk and HER2
- (2014) Kazem Ahmed Mahmoud et al. MedChemComm
- Architecture and Membrane Interactions of the EGF Receptor
- (2013) Anton Arkhipov et al. CELL
- DNA-Damaging Agents in Cancer Chemotherapy: Serendipity and Chemical Biology
- (2013) Kahlin Cheung-Ong et al. CHEMISTRY & BIOLOGY
- Synthesis of some dihydropyrimidine-based compounds bearing pyrazoline moiety and evaluation of their antiproliferative activity
- (2013) Fadi M. Awadallah et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- 4,5-Dihydro-1H-pyrazole: an indispensable scaffold
- (2013) Jimi Marin Alex et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- The ErbB/HER family of protein-tyrosine kinases and cancer
- (2013) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Design, synthesis and biological evaluation of pyrazolyl-thiazolinone derivatives as potential EGFR and HER-2 kinase inhibitors
- (2012) Ke-Ming Qiu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis and biological evaluation of novel coumarin–pyrazoline hybrids endowed with phenylsulfonyl moiety as antitumor agents
- (2012) Kamilia M. Amin et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Recent advances in the therapeutic applications of pyrazolines
- (2012) Mohamed R Shaaban et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Design and Synthesis of Novel Human Epidermal Growth Factor Receptor 2 (HER2)/Epidermal Growth Factor Receptor (EGFR) Dual Inhibitors Bearing a Pyrrolo[3,2-d]pyrimidine Scaffold
- (2011) Tomoyasu Ishikawa et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis, characterization, antiamoebic activity and cytotoxicity of novel series of pyrazoline derivatives bearing quinoline tail
- (2010) Faisal Hayat et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The role of HER2 in cancer therapy and targeted drug delivery
- (2010) Wanyi Tai et al. JOURNAL OF CONTROLLED RELEASE
- Promise and challenges in drug discovery and development of hybrid anticancer drugs
- (2009) Lalji K Gediya et al. Expert Opinion on Drug Discovery
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
- (2009) Oleg Trott et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- 4-Pyridylanilinothiazoles That Selectively Target von Hippel−Lindau Deficient Renal Cell Carcinoma Cells by Inducing Autophagic Cell Death
- (2009) Michael P. Hay et al. JOURNAL OF MEDICINAL CHEMISTRY
- A History of Cancer Chemotherapy
- (2008) Vincent T. DeVita et al. CANCER RESEARCH
- Synthesis and antimicrobial evaluation of 1-(benzofuran-2-yl)-4-nitro-3-arylbutan-1-ones and 3-(benzofuran-2-yl)-4,5-dihydro-5-aryl-1-[4-(aryl)-1,3-thiazol-2-yl]-1H-pyrazoles
- (2008) Bakr F. Abdel-Wahab et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started